A new generation of medications first developed for diabetes is now offering hope for chronic kidney disease patients. Three types of these drugs, including one famously known as Ozempic, are transforming the outlook for individuals who have long waited for more effective treatment options.
In 1900, Viennese instrument maker Erwin Perzy was asked to create a brighter light for a hospital’s operating room. The request aligned with a broader tech wave spurred by Thomas Edison’s 1879 patent, sparking innovative solutions in medical illumination.
Scientists have taken a curious concept once linked to an Ig Nobel prize and validated it in a human safety trial. Known as “butt-breathing” and formally called enteral ventilation, this technique might soon offer a new way to deliver oxygen.
Robert H. Bartlett, M.D., renowned as the Father of ECMO, has died at the age of 86 after a long illness. Bartlett was an active emeritus surgeon at Michigan Medicine and served as a professor at the University of Michigan Medical School.
Researchers at UTHealth Houston have made a significant leap toward decoding speech directly from the human brain. Their work, published in Nature Communications, points to a future where understanding silent thoughts and turning them into spoken words could become a reality.
With limited treatment options for stroke patients, two UConn researchers are developing a drug that aims to protect the brain and speed recovery. Strokes, or cerebral vascular accidents, can be life-altering, and this experimental therapy may offer a valuable new approach in addressing their debilitating impact.
